Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4. (Q42671834)

4 November 2017

title

Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4. (English)

1 reference

4 November 2017

1 reference

Harrop HA

1

1 reference

4 November 2017

Rider CC

series ordinal

2

1 reference

4 November 2017

publication date

1 February 1998

1 reference

4 November 2017

1 reference

4 November 2017

volume

8

1 reference

4 November 2017

issue

2

1 reference

4 November 2017

page(s)

131-137

1 reference

Sodium Pentosan Polysulfate (PPS), an Anti-HIV Agent Also Exhibits Synergism with AZT, Lymphoproliferative Activity, and Virus Enhancement

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Curdlan sulfate and HIV-1: II. In vitro long-term treatment of HIV-1 infection with curdlan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Activity of dextran sulfate and other polyanionic polysaccharides against human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Low anticoagulant heparin retains anti-HIV type 1 activity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Patterns of sulphation in heparan sulphate: polymorphism based on a common structural theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Mode of interaction between platelet factor 4 and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

Dextran sulphate, a potent anti-HIV agent in vitro having synergism with zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2F8.2.131

21 January 2018

Identifiers

DOI

10.1093/GLYCOB/8.2.131

1 reference

4 November 2017

1 reference